SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 931.36M
March 31, 2026 959.84M
December 31, 2025 960.14M
September 30, 2025 953.31M
June 30, 2025 955.96M
March 31, 2025 946.30M
December 31, 2024 962.99M
September 30, 2024 1.001B
June 30, 2024 1.008B
March 31, 2024 1.035B
December 31, 2023 1.045B
September 30, 2023 1.017B
June 30, 2023 1.017B
Date Value
March 31, 2023 1.040B
December 31, 2022 1.114B
September 30, 2022 1.151B
June 30, 2022 1.232B
March 31, 2022 1.265B
December 31, 2021 1.278B
September 30, 2021 1.282B
June 30, 2021 1.250B
March 31, 2021 1.222B
December 31, 2020 872.89M
September 30, 2020 583.86M
June 30, 2020 288.17M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
CellaVision AB 24.96M
ALR Technologies SG Ltd. --
M3, Inc. 696.25M
HealthStream, Inc. 84.63M
Simulations Plus, Inc. (DELISTED) 28.97M